Showing 1-10 of 2312 results for "".
- Jeffrey T. S. Hsu, MD, FAADhttps://practicaldermatology.com/profiles/jeffrey-t-s-hsu-md-faad/74v190/
Physician Spotlight: Jeffrey S. Dover, MD, FRCPC
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-jeffrey-s-dover-md-frcpc/23854/Physician Spotlight: Jeffrey M. Cohen, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-jeffrey-m-cohen-md/23555/The Colemans: Dermatology as a Father-Son(s) Tradition
https://practicaldermatology.com/topics/feature/colemans-dermatology-father-sons-tradition/26956/The Colemans: Dermatology as a Father-Son(s) Tradition“S or “C” Corporation for Your Practice
https://practicaldermatology.com/topics/practice-management/s-or-c-corporation-for-your-practice/21503/Maximize tax deductions by using both.Journal Club: S. Aureus-Driven AD Exacerbation
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-s-aureus-driven-ad-exacerbation/32404/Practical Dermatology Editorial Board member Christopher Bunick, MD, FAAD, discusses a recent Journal of Drugs in Dermatology article about the need for a novel treatment for S. aureus exacerbated atopic dermatitis with Adelaide Hebert, MD.Schachner LA, Andriessen A, Gonzalez ME, Lal K, Hebert AA, EPhysician Spotlight: Jeffrey P. Callen, MD, FACP, FAAD, MACR
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-jeffrey-p-callen-md-facp-faad-macr/20625/Understanding cutaneous manifestations of systemic diseaseWomen in Dermatology With S. Manjula Jegasothy, MD
https://practicaldermatology.com/topics/practice-management/women-in-dermatology-with-s-manjula-jegasothy-md/23173/Intergenerational Dermatologists: A Family Tradition in All Respects
https://practicaldermatology.com/topics/general-topics/intergenerational-dermatologists-a-family-tradition-in-all-respects/23977/With Sandra Lee, MD, and Jeffrey Rebish, MD, By Heidi SpleteThe Sernivo Formulation
https://practicaldermatology.com/topics/general-topics/the-sernivo-formulation-/18250/SERNIVO (betamethasone dipropionate) Spray, 0.05% is formulated to provide fast and powerful treatment for adult patients with mild to moderate plaque psoriasis. Dr. Jeffrey S. Fromowitz guides viewers through the mechanisms of SERNIVO in these video chapters.
- Prev
- Next